Semmelweis University Department of Rheumatology and ImmunologyAnifrolumabSystemic lupus erythematosusprednisoneSLE
…al study including SLE patients treated with anifrolumab at the Semmelweis University Department of Rheumatology and Immunology between 2022 and 2024. Demographic data, disease characteristic…